Anthony Letai, MD, PhD, FAACR, Lays Out NCI’s Priorities at the AACR Annual Meeting 2026
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
Researchers are examining ways to make treatments more targeted to each type of biliary tract cancer or to each...
Four past recipients of the Global Scholar-in-Training Award (GSITA) share how their experience at the AACR Annual Meeting impacted...
Before a new treatment becomes available for cancer patients, it must be tested in clinical trials and shown to be...
As World Cancer Day 2025 focuses on being "United by Unique," AACR shares how its initiatives help to connect...
This quarterly series on creative approaches to cancer research includes urine-powered nanomotors, unique molds to grow organoids, and more.
As winter marches on, let’s dive into the cool articles highlighted this month by the editors of the AACR...
A therapeutic HPV vaccine showed remarkable benefits for patients with high-grade cervical precancers.
Researchers share lessons from the first oncology clinical trial in Trinidad, which involved a patient named Faith Hill.
At the 2024 San Antonio Breast Cancer Symposium, researchers discussed clinical trials for vaccines and other ways to prevent...